2:36 PM
 | 
Sep 29, 2017
 |  BC Week In Review  |  Financial News  |  Completed Offerings

CAR T company Autolus raises $80M series C

On Sept. 26, chimeric antigen receptor (CAR) T cell therapy company Autolus Ltd. (London, U.K.) raised $80 million in a series C round from new investors Cormorant Asset Management and Nextech...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >